Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $261.25 USD
Change Today +1.70 / 0.65%
Volume 2.0M
PCYC On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Manmeet Singh Soni

Chief Financial Officer, Principal Accounting Officer and Treasurer, Pharmacyclics Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

36$3,518,262
As of Fiscal Year 2014

Background*

Mr. Manmeet Singh Soni has been the Chief Financial Officer of Pharmacyclics Inc. since February 4, 2014 and serves as its Principal Accounting Officer. Mr. Soni served as Senior Vice President of Finance at Pharmacyclics Inc. since August 2013, served as its Principal Financial Officer, Principal Accounting Officer and Treasurer since August 16, 2013. Mr. Soni served as Vice President and Corporate Controller at Pharmacyclics Inc. since February 2013.

Corporate Headquarters*

999 East Arques Avenue
Sunnyvale, California 94085

United States

Phone: 408-774-0330
Fax: 408-774-0340

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

Salary$421,565
Bonus$310,290
Total Annual Compensation$731,855

Stock Options*

Restricted Stock Awards$1,481,039
All Other Compensation$123,110
Exercised Options1,000
Exercised Options Value$79,842
Exercisable Options26,500
Unexercisable Options27,031
Total Value of Options$79,842
Total Number of Options118,000

Total Compensation*

Total Annual Cash Compensation$854,965
Total Short Term Compensation$731,855
Other Long Term Compensation$1,604,149
Total Calculated Compensation$3,518,262
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PCYC:US $261.25 USD +1.70

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jean-Jacques Bienaime MBAChief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$916.0K
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
$1.1M
Jean-Paul Clozel M.D.Founder, Chief Executive Officer, Member of Management Board and Director
Actelion Ltd.
SFr.2.7M
David L. Hallal Chief Executive Officer and Director
Alexion Pharmaceuticals, Inc.
$696.1K
Jan G. J. van de Winkel Ph.D.Co-Founder, Chief Executive Officer and President
Genmab A/S
kr11.0M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMACYCLICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.